Severe Covid-19 and acute pulmonary hypertension: 24-month follow-up regarding mortality and relationship to initial echocardiographic findings and biomarkers.
Joakim NorderfeldtAndreas LiliequistStaffan EksborgClaes G FrostellMaria J ErikssonChristofer AddingPer AgvaldPer-Arne LönnqvistPublished in: Acta anaesthesiologica Scandinavica (2022)
The mortality risk was increased up to 24 months after the initial examination in ICU-treated Covid-19 patients with a TTE diagnosis of aPH, compared to non-aPH patients. Certain individual TTE parameters were able to discriminate 24-month risk of morality.
Keyphrases
- pulmonary hypertension
- sars cov
- ejection fraction
- end stage renal disease
- newly diagnosed
- coronavirus disease
- chronic kidney disease
- intensive care unit
- liver failure
- cardiovascular events
- peritoneal dialysis
- pulmonary artery
- mitral valve
- early onset
- type diabetes
- risk factors
- heart failure
- respiratory failure
- pulmonary arterial hypertension
- cardiovascular disease
- coronary artery
- coronary artery disease
- mechanical ventilation
- patient reported outcomes
- hepatitis b virus
- left atrial
- patient reported